and Melanoma Cell Lines Leukemia/Lymphoma, Carcinoma, from Healthy Donors and in Lines Aminopeptidases in EBV-B Cell Expression of Endoplasmic Reticulum
Documents
Role of epigenetics in EBV regulation and pathogenesis
EBV Protein BNLF2a Exploits Host Tail-Anchored Protein Integration Machinery To Inhibit TAP
EBV-infected cord bloodderived mononuclear cell cultures activates T cells that inhibit B-cell proliferation in 4
[Neutralizing antibodies to immunomodulatory therapies in MS - part I] Неутрализиращи антитела към имуномодулиращи терапии при множествена
A Rapid and Reliable Enzyme Immunoassay PCR-Based Screening Method to Identify EBV-Carrying Gastric Carcinomas
Promocion EBV 2012
[Multiple sclerosis treatment] Лечение на множествена склероза.
A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly
Identification of Epstein-Barr Virus (EBV) Nuclear Antigen 2 (EBNA2) Target Proteins by Proteome Analysis: Activation of EBNA2 in Conditionally Immortalized B Cells Reflects Early
EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines
Functional and Physical Interactions between the Epstein-Barr Virus (EBV) Proteins BZLF1 and BMRF1: Effects on EBV Transcription and Lytic Replication
Epstein-Barr Virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma
EBV-associated malignancies
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
Statin-induced changes in gene expression in EBV-transformed and native B-cells
Concomitant increase of LMP1 and CD25 (IL-2-receptor α) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
![Page 1: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/1.jpg)
![Page 2: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/2.jpg)
![Page 3: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/3.jpg)
![Page 4: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/4.jpg)
![Page 5: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/5.jpg)
![Page 6: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/6.jpg)
![Page 7: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/7.jpg)
![Page 8: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/8.jpg)
![Page 9: [Migrant studies and role of EBV in multiple sclerosis] Миграционни проучвания и роля на EBV при множествена склероза.](https://reader039.documents.pub/reader039/viewer/2023042014/6333384db6829c19b80c4f45/html5/page/9.jpg)
![[Neutralizing antibodies to immunomodulatory therapies in MS - part I] Неутрализиращи антитела към имуномодулиращи терапии при множествена](https://static.documents.pub/doc/80x56/63333876ce61be0ae50e8a6f/neutralizing-antibodies-to-immunomodulatory-therapies-in-ms-part-i-neutralizirashchi.jpg)
![[Multiple sclerosis treatment] Лечение на множествена склероза.](https://static.documents.pub/doc/80x56/6333393e3d0bcb45f503fc20/multiple-sclerosis-treatment-lechenie-na-mnozhestvena-skleroza.jpg)
